MedTrace Logo

The Effect of Primary Care Opioid Taper Plans on Sustained Opioid Taper

NCT03748862 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2019-08-21

No results posted yet for this study

Summary

The objective of this study is to examine the effects of opioid taper plans as documented in the electronic medical record for Kaiser Permanente Washington (KPWA) patients. The study will compare different types of opioid tapering plans and will report on their effectiveness in producing sustained taper or discontinuation of long-term opioid therapy for chronic non-cancer pain while maintaining adequate pain control. The study population is KPWA patients receiving long-term opioid therapy from 2010 to 2017.

Conditions

  • Opiate Replacement Therapy

Interventions

OTHER

Taper Plan

Occurrence of a taper plan defined by a primary care provider during the follow-up period. Evidence of a taper plan will be obtained by searching prescriptions (SIGs) and medical encounter notes using natural language processing (NLP).

Sponsors & Collaborators

Principal Investigators

  • Mark Sullivan, MD, PhD · University of Washington

  • David S Carrell, PhD · Kaiser Permanente

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-10-30
Completion
2019-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03748862 on ClinicalTrials.gov